tofacitinib

Zydus Pharmaceuticals USA Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 7, 2026
Approval ID: 179ffbb2-bedc-40e6-b77b-33d4f7832172
Products: 2 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TOFACITINIB EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for TOFACITINIB EXTENDED-RELEASE TABLETS. TOFACITINIB extended-release tablets, for oral useInitial U.S. Approval: 2012

Quick Stats

Total Products2

Labelers1

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.